Molina Healthcare Inc (NYSE:MOH) had its price objective boosted by stock analysts at Morgan Stanley from $68.00 to $89.00 in a research note issued to investors on Friday. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 12.40% from the stock’s current price.
A number of other equities research analysts also recently issued reports on the company. Jefferies Group LLC reiterated a “hold” rating and issued a $74.00 price objective (up previously from $64.00) on shares of Molina Healthcare in a research report on Friday. Wolfe Research upgraded Molina Healthcare from a “market perform” rating to an “outperform” rating in a research report on Monday, October 23rd. BMO Capital Markets began coverage on Molina Healthcare in a research report on Monday, October 16th. They issued a “market perform” rating and a $70.00 price objective on the stock. Zacks Investment Research downgraded Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, October 3rd. Finally, Mitsubishi UFJ Financial Group assumed coverage on Molina Healthcare in a research report on Thursday, September 21st. They issued a “neutral” rating and a $70.00 price objective on the stock. Four analysts have rated the stock with a sell rating, nine have given a hold rating and five have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $64.30.
Shares of Molina Healthcare (NYSE:MOH) traded up $11.00 during mid-day trading on Friday, hitting $79.18. The company had a trading volume of 6,310,768 shares, compared to its average volume of 1,287,506. The company has a market cap of $3.94 billion, a PE ratio of 21.43 and a beta of 0.91.
Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Thursday, November 2nd. The company reported ($1.62) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a positive return on equity of 17.21% and a negative net margin of 1.76%. The business had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $4.95 billion. During the same quarter last year, the business posted $0.85 EPS. The company’s quarterly revenue was up 10.7% on a year-over-year basis. equities research analysts predict that Molina Healthcare will post -2.14 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Molina Healthcare Inc (MOH) PT Raised to $89.00 at Morgan Stanley” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.com-unik.info/2017/11/03/molina-healthcare-inc-moh-pt-raised-to-89-00-at-morgan-stanley.html.
In other news, insider William Dentino sold 66,000 shares of the firm’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $60.09, for a total transaction of $3,965,940.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $60.00, for a total value of $60,000.00. The disclosure for this sale can be found here. Insiders have sold 398,853 shares of company stock worth $25,242,273 over the last ninety days. Insiders own 6.20% of the company’s stock.
Several large investors have recently made changes to their positions in the company. BNP Paribas Arbitrage SA grew its stake in shares of Molina Healthcare by 5.9% during the third quarter. BNP Paribas Arbitrage SA now owns 270,981 shares of the company’s stock valued at $18,633,000 after buying an additional 15,180 shares during the last quarter. Principal Financial Group Inc. grew its stake in shares of Molina Healthcare by 2.8% during the third quarter. Principal Financial Group Inc. now owns 192,315 shares of the company’s stock valued at $13,224,000 after buying an additional 5,181 shares during the last quarter. Frontier Capital Management Co. LLC grew its stake in shares of Molina Healthcare by 55.7% during the third quarter. Frontier Capital Management Co. LLC now owns 178,323 shares of the company’s stock valued at $12,261,000 after buying an additional 63,810 shares during the last quarter. Tavio Capital LLC grew its stake in shares of Molina Healthcare by 418.0% during the third quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock valued at $36,937,000 after buying an additional 433,485 shares during the last quarter. Finally, Crossmark Global Holdings Inc. bought a new position in shares of Molina Healthcare during the third quarter valued at about $586,000. 95.22% of the stock is currently owned by hedge funds and other institutional investors.
Molina Healthcare Company Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
What are top analysts saying about Molina Healthcare Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Molina Healthcare Inc and related companies.